OrbiMed's Health Diagnostics Portfolio

A private biopharmaceutical company .

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.